Synthesis and anticancer activity evaluation of 3-(4-oxo-2-thioxothiazolidin-5-yl)-1H-indole-carboxylic acids derivatives

References

• Bommagani, S.; Ponder, J.; Penthala, N. R.; Janganati, V.; Jordan, C. T.; Borrelli, M. J.; Crooks, P. A. Indole Carboxylic Acid Esters of Melampomagnolide B Are Potent Anticancer Agents against Both Hematological and Solid Tumor Cells. Eur. J. Med. Chem. 2017, 136, 393–405. DOI: 10.1016/j.ejmech.2017.05.031.
   PubMed Web of Science ®Google Scholar
• Li, S. M. Prenylated Indole Derivatives from Fungi: Structure Diversity, Biological Activities, Biosynthesis and Chemoenzymatic Synthesis. Nat. Prod. Rep. 2010, 27, 57–78. DOI: 10.1039/b909987p.
   PubMed Web of Science ®Google Scholar
• O'Connor, S. E.; Maresh, J. Chemistry and Biology of Monoterpene Indole Alkaloid Biosynthesis. Nat. Prod. Rep. 2006, 23, 532–547. DOI: 10.1039/b512615k.
   PubMed Web of Science ®Google Scholar
• Kaushik, N. K.; Kaushik, N.; Attri, P.; Kumar, N.; Kim, C. H.; Verma, A. K.; Choi, E. H. Biomedical Importance of Indoles. Molecules. 2013, 18, 6620–6662. DOI: 10.3390/molecules18066620.
   PubMed Web of Science ®Google Scholar
• Kumar, D.; Kumar, N. M.; Akamatsu, K.; Kusaka, E.; Harada, H.; Ito, T. Synthesis and Biological Evaluation of Indolyl Chalcones as Antitumor Agents. Bioorg. Med. Chem. Lett. 2010, 20, 3916–3919. DOI: 10.1016/j.bmcl.2010.05.016.
   PubMed Web of Science ®Google Scholar
• Patil, S. A.; Patil, R.; Miller, D. D. Indole Molecules as Inhibitors of Tubulin Polymerization: Potential New Anticancer Agents. Future Med. Chem. 2012, 4, 2085–2115. DOI: 10.4155/fmc.12.141.
   PubMed Web of Science ®Google Scholar
• Patil, R.; Patil, S. A.; Beaman, K. D.; Patil, S. A. Indole Molecules as Inhibitors of Tubulin Polymerization: potential New Anticancer Agents, an Update (2013–2015). Future Med. Chem. 2016, 8, 1291–1316. DOI: 10.4155/fmc-2016-0047.
   PubMed Web of Science ®Google Scholar
• Zhang, M. Z.; Chen, Q.; Yang, G. F. A Review on Recent Developments of Indole-Containing Antiviral Agents. Eur. J. Med. Chem. 2015, 89, 421–441. DOI: 10.1016/j.ejmech.2014.10.065.
   PubMed Web of Science ®Google Scholar
• Zhang, M. Z.; Mulholland, N.; Beattie, D.; Irwin, D.; Gu, Y. C.; Chen, Q.; Yang, G. F.; Clough, J. Synthesis and Antifungal Activity of 3-(1,3,4-Oxadiazol-5-yl)-Indoles and 3-(1,3,4-Oxadiazol-5-yl)Methyl-Indoles. Eur. J. Med. Chem. 2013, 63, 22–32. DOI: 10.1016/j.ejmech.2013.01.038.
   PubMed Web of Science ®Google Scholar
• Brancale, A.; Silvestri, R. Indole, a Core Nucleus for Potent Inhibitors of Tubulin Polymerization. Med. Res. Rev. 2007, 27, 209–238. DOI: 10.1002/med.20080.
   PubMed Web of Science ®Google Scholar
• Granchi, C.; Roy, S.; De Simone, A.; Salvetti, I.; Tuccinardi, T.; Martinelli, A.; Macchia, M.; Lanza, M.; Betti, L.; Giannaccini, G.; et al. N-Hydroxyindole-Based Inhibitors of Lactate Dehydrogenase against Cancer Cell Proliferation. Eur. J. Med. Chem. 2011, 46, 5398–5407. DOI: 10.1016/j.ejmech.2011.08.046.
   PubMed Web of Science ®Google Scholar
• Kaminskyy, D.; den Hartog, G. J.; Wojtyra, M.; Lelyukh, M.; Gzella, A.; Bast, A.; Lesyk, R. Antifibrotic and Anticancer Action of 5-Ene Amino/Iminothiazolidinones. Eur. J. Med. Chem. 2016, 112, 180–195. DOI: 10.1016/j.ejmech.2016.02.011.
   PubMed Web of Science ®Google Scholar
• Kaminskyy, D.; Kryshchyshyn, A.; Lesyk, R. 5-Ene-4-Thiazolidinones – An Efficient Tool in Medicinal Chemistry. Eur. J. Med. Chem. 2017, 140, 542–594. DOI: 10.1016/j.ejmech.2017.09.031.
   PubMed Web of Science ®Google Scholar
• Kaminskyy, D.; Kryshchyshyn, A.; Lesyk, R. Recent Developments with Rhodanine as a Scaffold for Drug Discovery. Expert Opin. Drug Dis. 2017, 12, 1233–1252. DOI: 10.1080/17460441.2017.1388370.
   PubMed Web of Science ®Google Scholar
• Kryshchyshyn, A.; Kaminskyy, D.; Karpenko, O.; Gzella, A.; Grellier, P.; Lesyk, R. Thiazolidinone/Thiazole Based hybrids - New Class of Antitrypanosomal Agents. Eur. J. Med. Chem. 2019, 174, 292–308. DOI: 10.1016/j.ejmech.2019.04.052.
   PubMed Web of Science ®Google Scholar
• Font, M.; Monge, A.; Cuartero, A.; Elorriaga, A.; Martínez-Irujo, J. J.; Alberdi, E.; Santiago, E.; Prieto, I.; Lasarte, J. J.; Sarobe, P.; Borrás, F. Indoles and Pyridazino[4,5-b]Indoles as Nonnucleoside Analog Inhibitors of HIV-1 Reverse Transcriptase. Eur. J. Med. Chem. 1995, 30, 963–971. DOI: 10.1016/0223-5234(96)88316-4.
   Web of Science ®Google Scholar
• Kaminskyy, D.; Kryshchyshyn, A.; Nektegayev, I.; Vasylenko, O.; Grellier, P.; Lesyk, R. Isothiocoumarin-3-Carboxylic Acid Derivatives: synthesis, Anticancer and Antitrypanosomal Activity Evaluation. Eur. J. Med. Chem. 2014, 75, 57–66. DOI: 10.1016/j.ejmech.2014.01.028.
   PubMed Web of Science ®Google Scholar
• Kaminskyy, D.; Khyluk, D.; Vasylenko, O.; Lesyk, R. An Efficient Method for the Transformation of 5-Ylidenerhodanines into 2,3,5-Trisubstituted-4-Thiazolidinones. Tetrahedron Lett. 2012, 53, 557–559. DOI: 10.1016/j.tetlet.2011.11.095.
   Web of Science ®Google Scholar
• Zhao, Y.; Truhlar, D. G. The M06 Suite of Density Functionals for Main Group Thermochemistry, Thermochemical Kinetics, Noncovalent Interactions, Excited States, and Transition Elements: two New Functionals and Systematic Testing of Four M06-Class Functionals and 12 Other Functionals. Theor. Chem. Account. 2008, 120, 215–241. DOI: 10.1007/s00214-007-0310-x.
   Web of Science ®Google Scholar
• Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; et al. Gaussian 09, Revision D.01; Gaussian, Inc.: Wallingford, CT, 2013.
   Google Scholar
• Cossi, M.; Rega, N.; Scalmani, G.; Barone, V. Energies, Structures, and Electronic Properties of Molecules in Solution with the C-PCM Solvation Model. J. Comput. Chem. 2003, 24, 669–681. DOI: 10.1002/jcc.10189.
   PubMed Web of Science ®Google Scholar
• Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; et al. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. J. Natl. Cancer Inst. 1991, 83, 757–766. DOI: 10.1093/jnci/83.11.757.
   PubMed Web of Science ®Google Scholar
• Boyd, M. R.; Paull, K. D. Some Practical Considerations and Applications of the National Cancer Institute in Vitro Anticancer Drug Discovery Screen. Drug Dev. Res. 1995, 34, 91–109. DOI: 10.1002/ddr.430340203.
   Web of Science ®Google Scholar
• Boyd, M. R. The NCI In Vitro Anticancer Drug Discovery Screen. In Anticancer Drug Development Guide. Cancer Drug Discovery and Development; Teicher B. A., Eds.; Humana Press, Totowa, NJ. 1997; Vol. 2, pp. 23–42.
   Google Scholar
• Shoemaker, R. H. The NCI60 Human Tumour Cell Line Anticancer Drug Screen. Nat. Rev. Cancer. 2006, 6, 813–823. DOI: 10.1038/nrc1951.
   PubMed Web of Science ®Google Scholar
• Rostom, S. A. F. Synthesis and in Vitro Antitumor Evaluation of Some Indeno[1,2-c]Pyrazol(in)es Substituted with Sulfonamide, Sulfonylurea(-Thiourea) Pharmacophores, and Some Derived Thiazole Ring Systems. Bioorg. Med. Chem. 2006, 14, 6475–6485. DOI: 10.1016/j.bmc.2006.06.020.
   PubMed Web of Science ®Google Scholar